CrossWork

DataRobot, Inc. develops an automated machine learning platform designed to help enterprises build predictive models efficiently. The company's offerings include DataRobot Cloud, a predictive analytics platform available on-site or via the cloud, and DataRobot MLOps, which focuses on the deployment, monitoring, and management of machine learning models within organizations. Additionally, DataRobot Enterprise provides features such as flexible deployment, governance, and support, along with packages aimed at accelerating artificial intelligence projects and education services. The platform is suitable for a diverse range of professionals, including business analysts, data scientists, and IT specialists across various industries like banking, healthcare, and marketing. Founded in 2012 and headquartered in Boston, Massachusetts, DataRobot also maintains operations in several international locations, including London, Paris, Kyiv, Tokyo, and Singapore. The company has established strategic partnerships to enhance its offerings in the competitive AI landscape.

Tradeshift Inc. is a cloud-based platform that connects buyers and suppliers, streamlining digital trade transactions and enhancing supply chain efficiency. Founded in 2009 and headquartered in San Francisco, California, Tradeshift offers a suite of solutions including Tradeshift Buy, an eProcurement tool; Tradeshift Pay, an accounts payable automation platform; and Tradeshift Risk, which focuses on risk data collection and analysis. The company also provides Tradeshift Engage, a platform for supplier collaboration, and Tradeshift Go, which offers visibility into employee spending. Additionally, Tradeshift Frontiers serves as an innovation lab, exploring emerging technologies such as artificial intelligence and distributed ledgers to transform B2B commerce and global supply chains. With a commitment to eliminating paper and manual processes, Tradeshift enables clients to optimize procure-to-pay processes securely while capitalizing on early payment discounts and minimizing risks.

GeneToBe offers a gene editing platform that corrects mutations to cure common and rare genetic diseases. They also offer genetic therapies for cystic fibrosis causing mutations and usher syndrome patients.

Stripe, Inc. is a global technology company that provides application programming interfaces (APIs) and tools designed to facilitate online payment processing for businesses. Its comprehensive platform includes solutions for payments, subscriptions, fraud detection, and data analytics, among others. Stripe's offerings, such as Stripe Connect for routing payments, Stripe Radar for fraud prevention, and Stripe Checkout for seamless transaction processes, cater to a diverse clientele ranging from startups to established enterprises. The company also addresses financing challenges faced by online businesses through Stripe Capital, which offers fast and flexible funding options. With operations in multiple countries, including the United States, the United Kingdom, and Singapore, Stripe aims to simplify financial infrastructure and support the growth of internet-based businesses, thereby contributing to the overall economic landscape of the digital economy. Founded in 2010 and headquartered in San Francisco, California, Stripe has established partnerships with leading technology firms to enhance its service capabilities.

Response Pharmaceuticals is a biotechnology and pharmaceutical company.